BEAFORE BrandsTM, Inc. , a science-based consumer product company dedicated to bringing innovative, proprietary nutritional products directly to families, today announced that it has raised $13. 1 million in private financing in the Series A financing round led by Gurnet Point Capital
Co-founded by businessman Dr. Ashley Dombkowski and Dr. Pediatrician Kari Nadeau, BEFORE Brands’ products build on a growing body of evidence to support nutritional strategies that include potentially allergenic foods as a regular part of a healthy diet. The products are based on insight and intellectual property developed by Dr. Nadeau is licensed to BEFORE Brands by Stanford University on an exclusive, global basis. The Company’s Early Adaptive ToleranceTM edible products are intended to be incorporated into infant diets of around 6 months of age as part of the introduction of solid food. This proprietary platform embraces ideals from the intersection of dietary supplements, natural foods, and infant nutrition categories.
‘Food allergies are an accelerated epidemic, now affecting about two children per classroom in the United States and doubling every 10 years. As a clinician and researcher, I study the interaction between genetics and environmental influences such as diet in the context of food allergies and asthma. BEFORE Brands will soon be marketing a line of products based on these insights designed specifically for healthy infants and toddlers to complement a diverse, fresh and healthy diet while the immune system is developing. Our products use our proprietary Early Adaptive Tolerance system, which is consistent with independently generated evidence to support the ‘early and often’ introduction of typical allergenic foods, such as peanut, in infant diets,’ said Dr. Nadeau is a full-time Naddisy Foundation Professor of Medicine and Pediatrics and Director of Sean N. Parker Center for Research on Allergy and Asthma at Stanford University
‘Our first-of-its-kind product line benefits from proprietary insights from one of the world’s leading experts in adult and pediatric allergies, alongside world-class development and marketing capabilities. Our team appreciates the commitment and expertise of Gurnet Point Capital to help us expand our reach quickly and responsibly, and looks forward to working closely with Gurnet Point during this important phase of our company’s growth,” said Dr. Dombkowski, Chief Executive Officer of the Company
‘The BEFORE Brands team is building a company that combines scientific rigor and the creativity of a consumer company to serve young families. We are thrilled to use the operating expertise and resources of Gurnet Point Capital to support the vision of this outstanding entrepreneurial team,” said George Montgomery, Partner at Gurnet Point Capital and a member of the Board of Directors of the company.
The Syndicate Series A included investments by Martha Goldberg Aronson & Dan Aronson, Justine & John Arrillaga, Denise & Dave Bunning, Michele & Tim Barakett, Katherine Collins, Linda & Bill Friend, Kim & Alan Hartman, Melissa & Scott Kepner, Rebecca & Sasha Lainovic, Michelle & Daniel Lubetzky, Julie & Bruce Menin, Shirley & Mike Orsak, Melanie & Sasha
The company is located in Menlo Park, CA.
About BEFORE Brands, Inc.
Immune system: part of the soldier, part of the sentinel An essential balance, perfected by time, but increasingly disturbed by modern living BEFORE Brands develops edible products to support this critical duality, starting with healthy infants before problems arise. Our products use our proprietary Early Adaptive ToleranceTM blend of whole food proteins & vitamin D to help ensure balanced, gentle and consistent immune system support right from the start. This technology has been developed by Dr. Kari Nadeau, a pediatrician, mother of five, and Sean N Director. Parker Center for Research on Allergy and Asthma at Stanford University Our products build on a growing body of evidence to support nutritional strategies that include potentially allergenic foods as a regular part of a healthy diet. We Nourish PossibilitiesTM at BEFORE Brands Please visit www for more information. Prebrands Come on,
About the Capital Gurnet Point
Gurnet Point Capital (GPC) is a unique health care fund founded by Ernesto Bertarelli and headed by Christopher A. Viehbacher, who together have decades of expertise in an industry for which they share a passion, both as Chief Executive Officers and as investors With an initial allocation of $2 billion, GPC is investing long-term capital and supporting entrepreneurs to build a new generation of companies. Based in Cambridge, MA, its remit is global, encompassing life sciences and medical technology. The Fund invests through all stages of product development through commercialisation, and does so with a hybrid approach of venture and private equity investment strategies. This approach is governed by a guiding principle that even the earliest technologies must present a clear commercial case, benefiting both patients and the healthcare system as a whole.
Please note that this piece of work originally appeared in English at https://www.vcnewsdaily.com/BEFORE%20Brands/venture-funding.php. As Investocracy aims to bring global startup news and updates in both English and Japanese to you, it’s important that we attribute original source to you. If you have any questions/concerns please write to us at contact@investocracy.co
